Showing results (1151-1160 of 2,583) with videos related to

Sort By:
Pageof 259
Molecular Oncology|January 22, 2025
Clinical significance of stratifying prostate cancer patients through specific circulating genesSeta Derderian, Edouard Jarry, Arynne Santos, et al.
Molecular Oncology|January 6, 2025
Multi-omics profiling reveals key factors involved in Ewing sarcoma metastasisMariona Chicón-Bosch, Sara Sánchez-Serra, Marta Rosàs-Lapeña, et al.
Molecular Oncology|January 4, 2025
Detection rate for ESR1 mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCRStavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, et al.
Molecular Oncology|January 14, 2025
Obesity alters the fitness of peritumoral adipose tissue, exacerbating tumor invasiveness in renal cancer through the induction of ADAM12 and CYP1B1Sepehr Torabinejad, Caterina Miro, Annarita Nappi, et al.
Molecular Oncology|January 10, 2025
The PTTG1/VASP axis promotes oral squamous cell carcinoma metastasis by modulating focal adhesion and actin filamentsSuyeon Park, Sang Shin Lee, Shihyun Kim, et al.
Molecular Oncology|January 8, 2025
CRISPR targeting of FOXL2 c.402C>G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti-tumoral compoundsSandra Amarilla-Quintana, Paloma Navarro, Iván Hernández, et al.
Molecular Oncology|January 9, 2025
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective studyValerio Gristina, Viviana Bazan, Nadia Barraco, et al.
Molecular Oncology|January 4, 2025
KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cellsLuisa Brock, Lina Benzien, Sandra Lange, et al.
Molecular Oncology|March 11, 2025
The atypical KRASQ22K mutation directs TGF-β response towards partial epithelial-to-mesenchymal transition in patient-derived colorectal cancer tumoroidsTheresia Mair, Philip König, Milena Mijović, et al.
Molecular Oncology|December 4, 2024
A two-phase epigenome-wide four-way gene-smoking interaction study of overall survival for early-stage non-small cell lung cancerLeyi Chen, Xiang Wang, Ning Xie, et al.
Pageof 259